Open AccessThe use of European Randomized study of Screening for Prostate Cancer calculator as a diagnostic tool for prostate biopsy indication
Author(s) -
J Breza,
F. Šubin,
M Bernadic,
Maja Ilić Tomaš,
Daniel Pinďák
Publication year - 2019
Publication title -
bratislavské lekárske listy/bratislava medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 32
eISSN - 1336-0345
pISSN - 0006-9248
DOI - 10.4149/bll_2019_054
Subject(s) - prostate cancer , rectal examination , medicine , prostate biopsy , biopsy , prostate , prostate specific antigen , urology , prostate cancer screening , gynecology , oncology , cancer
It is a well-known fact, that too many men are having prostate biopsy performed with negative biopsy results. The decision to undertake prostate biopsy is usually based on prostate specific antigen (PSA) level and digital rectal examination (DRE). A risk-based strategy may reduce the numbers of unnecessary prostate biopsies.